Nivaan, a company dedicated to transforming pain management in India, has successfully secured $7.0 million in its latest funding round. This capital infusion marks a significant milestone for the company as it aims to expand its reach and enhance its specialized treatment offerings across the country.
The company addresses the pervasive issue of chronic musculoskeletal (MSK) pain, a condition that affects a substantial portion of the population and is often poorly managed. Nivaan distinguishes itself by offering a 360-degree diagnosis and treatment approach for pain of all origins. Its multidisciplinary team comprises Pain Management Specialists, Physiotherapists, Nutritionists, and Pain Therapists, who collaborate to deliver effective, non-surgical relief. This comprehensive strategy focuses on reducing medicine dependency and improving patient mobility.
The newly raised funds are earmarked to accelerate Nivaan's strategic growth initiatives. The company plans to expand its presence into more cities, making its cutting-edge, non-invasive, and multidisciplinary treatments accessible to a broader patient base. This expansion is crucial for Nivaan to scale its proven protocols, which have already helped thousands of patients achieve pain-free lives without the need for surgery.
This investment underscores confidence in Nivaan's innovative model and its potential to significantly impact public health by providing sustainable solutions for chronic pain. With this capital, Nivaan is well-positioned to continue its mission of empowering more individuals to live pain-free, reduce reliance on medication, and regain their mobility across India.
.png&w=3840&q=75)
